(Q37102352)

18 August 2017

1 reference

title

Systematic review of statistical methods used in molecular marker studies in cancer (English)

1 reference

18 August 2017

0 references

1 reference

Hans Lilja

4

0 references

Daniel J. Sargent

object named as

Daniel Sargent

3

0 references

Andrew Vickers

object named as

Andrew J Vickers

1

0 references

author name string

Kwang Jang

2

1 reference

18 August 2017

Michael W Kattan

5

1 reference

18 August 2017

language of work or name

English

0 references

publication date

1 April 2008

1 reference

18 August 2017

1 reference

18 August 2017

112

1 reference

18 August 2017

8

1 reference

18 August 2017

1862-1868

1 reference

Long-term prediction of prostate cancer up to 25 years before diagnosis of prostate cancer using prostate kallikreins measured at age 44 to 50 years.

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675946

Decision curve analysis: a novel method for evaluating prediction models

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675946

DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675946

Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675946

Biomarkers in cancer staging, prognosis and treatment selection

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675946

Autoantibody signatures in prostate cancer

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675946

Clinical trial designs for predictive marker validation in cancer treatment trials

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675946

Accuracy of screening mammography interpretation by characteristics of radiologists

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675946

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675946

Prognostic and predictive markers in cancer

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675946

Circulating tumor cells, disease progression, and survival in metastatic breast cancer

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675946

Biostatistics and Tumor Marker Studies in Breast Cancer: Design, Analysis and Interpretation Issues

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675946

Molecular predictors of survival after adjuvant chemotherapy for colon cancer

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675946

Decision curve analysis: a discussion

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675946

Reporting recommendations for tumor marker prognostic studies (REMARK).

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675946

Evaluating a new marker's predictive contribution.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675946

Selective reporting biases in cancer prognostic factor studies

3 September 2018

1 reference

12 December 2020

Relevance of Urine Telomerase in the Diagnosis of Bladder Cancer

1 reference

12 December 2020

Quality of reporting of cancer prognostic marker studies: association with reported prognostic effect

1 reference

12 December 2020

Statistical issues in tumor marker studies

1 reference

12 December 2020

Issues in clinical trial design for tumor marker studies

1 reference

12 December 2020

Outcome prediction and the future of the TNM staging system

1 reference

12 December 2020

Identifiers

DOI

10.1002/CNCR.23365

1 reference

18 August 2017

1 reference

18 August 2017

PubMed publication ID

18320601

1 reference